Evaluation of Smallpox Vaccination Coverage and Attitude towards Monkeypox Vaccination among Healthcare Workers in an Italian University Hospital
(1) Background: In 2022, monkeypox (Mpox) was declared a public health emergency. The European Medicines Agency has authorized the use of Imvanex/Jynneos, a smallpox vaccine, for coverage against pox. Healthcare workers (HCWs) are all considered by the European Centre for Disease Prevention and Cont...
Main Authors: | Sergio Scarinci, Martina Padovan, Bianca Cosci, Armando Petillo, Vittorio Gattini, Francesca Cosentino, Aldo Mignani, Rudy Foddis, Giovanni Guglielmi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/12/1741 |
Similar Items
-
Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults
by: Iván Sanz-Muñoz, et al.
Published: (2023-03-01) -
Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China
by: Yu Huang, et al.
Published: (2024-02-01) -
A narrative review of pox: smallpox vs monkeypox
by: Samiksha Jayswal, et al.
Published: (2022-12-01) -
Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study
by: Noriko Tomita, et al.
Published: (2023-03-01) -
Human monkeypox — After 40 years, an unintended consequence of smallpox eradication
by: Hussain Haider Shah, et al.
Published: (2023-01-01)